GlaxoSmithKline Biologicals S.A.
UkraineAll drugs from this manufacturer
-
The vaccine is intended for the prevention of hepatitis A virus by stimulating the body's immune response. It is recommended for individuals in high-risk groups, including travelers, military personnel, medical staff, people with chronic liver diseases, and other categories who may come into contact with the virus.
Dosage form: suspension for injection
Active substance Dosage hepatitis a virus antigen 1440 IU ELISA ATC: J07BC02
-
The vaccine is intended for the prevention of hepatitis A virus. It is recommended for individuals in risk groups, including travelers, military personnel, medical staff, people with chronic liver diseases, or those who come into contact with infected individuals.
Dosage form: suspension for injection
Active substance Dosage hepatitis a virus antigen 720 ELISA units ATC: J07BC02
-
The vaccine is intended for the active immunization of people of all age groups for the prevention of infections caused by poliovirus types 1 and 3.
Dosage form: suspension, oral
Active substance Dosage poliovirus type 1 strain lsc 2ab 106.0 CCID50 poliovirus type 3 leon 12a 1b strain 105.8 CCID50 ATC: J07BF04
-
The vaccine is used for the prophylaxis of rotavirus gastroenteritis.
Dosage form: suspension, oral
Active substance Dosage human rotavirus live attenuated rix4414 strain not less than 106.0 TCID50 ATC: J07BH01